INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 September 2014
Net Assets |
£218m |
Net Assets per share |
402p |
Share price |
321p |
Total value of unquoted investments |
£19m |
Total number of portfolio companies |
90 |
Top Ten Holdings
Company Name |
% NAV |
Gilead |
8.1 |
Regeneron |
6.9 |
Celgene |
6.9 |
Biogen-Idec |
5.0 |
Alexion |
4.7 |
Amgen |
4.2 |
Illumina |
3.6 |
Chimerix |
3.3 |
Actelion |
2.9 |
Biomarin |
2.9 |
|
----------- |
Total |
48.5 |
Portfolio Profitability |
% NAV |
Profitable |
62 |
Turning Profitable 2015 |
6 |
Unprofitable |
32 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
87 |
Europe & UK |
13 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
92 |
Unquoted |
8 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
30 OCTOBER 2014